Industry’s View on Using Quality Control, Biorelevant and Clinically Relevant Dissolution Tests for Pharmaceutical Development, Registration and Commercialization

Journal of Pharmaceutical Sciences - United States
doi 10.1016/j.xphs.2017.10.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Biorelevant Dissolution of Candesartan Cilexetil

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

In-Process and Finished Products Quality Control Tests for Pharmaceutical Capsules According to Pharmacopoeias

British Journal of Pharmaceutical Research
2016English

Clinically Relevant Quality Measures for Risk Factor Control in Primary Care: A Retrospective Cohort Study

BMC Health Services Research
Health Policy
2014English

Development of a Clinically Relevant Endoscopic Grading System for Chronic Rhinosinusitis Using Canonical Correlation Analysis

International Forum of Allergy and Rhinology
OtorhinolaryngologyAllergyImmunology
2015English

Proposed Quality Control Guidelines for Antimicrobial Susceptibility Tests Using Tilmicosin.

Journal of Clinical Microbiology
Microbiology
1995English

Simplified Biorelevant Media for Screening Dissolution Performance of Poorly Soluble Drugs

Dissolution Technologies
Pharmaceutical Science
2007English

Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections

Frontiers in Microbiology
Microbiology
2018English

Display Metrology and Image Quality Are Relevant, Vital for Development

Information Display
HardwareElectronic EngineeringElectricalArchitecture
2018English

Clinically Relevant Findings.

Journal of Clinical Investigation
Medicine
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy